Clinical Trial

State of Oxygen Metabolism, Cardiovascular and Respiratory System Reserve Capacity in Patients Who Underwent COVID-19

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 11, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This clinical study will create an evidence base for rehabilitation approach, which will be used for restoration of pulmonary ventilation and gas exchange, increase of tolerance to physical load reduced in patients who underwent COVID-19. The aim of the present clinical study is to evaluate the effectiveness of medical rehabilitation of COVID-19 patients based on the study of individual physiological parameters of oxygen metabolism and reserve capabilities of the cardiovascular and respiratory systems.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-18; most recent amendment 2025-02-07.
Status change: Recruiting → Active, Not Recruiting 2025-02-07
Trial Details
NCT Number NCT05911100
Lead Sponsor Meshalkin Research Institute of Pathology of Circulation
Conditions Covid19, COVID19 Infection
Enrollment 100 participants
Start Date 2020-08-25
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-11